NEJM Group Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Publishing

Industry

Estimated Revenue & Valuation

  • NEJM Group's estimated annual revenue is currently $75.9M per year.(i)
  • NEJM Group's estimated revenue per employee is $267,300

Employee Data

  • NEJM Group has 284 Employees.(i)
  • NEJM Group grew their employee count by 6% last year.

NEJM Group's People

NameTitleEmail/Phone
1
Director Market IntelligenceReveal Email/Phone
2
Director, Brand Development and Strategic MarketingReveal Email/Phone
3
Managing Director, NEJM Group Research & PublishingReveal Email/Phone
4
Director, Human ResourcesReveal Email/Phone
5
Director, Digital Strategy & ExperienceReveal Email/Phone
6
Editorial Manager, Systems and Operations, Clinical ProgramsReveal Email/Phone
7
Online Subscription Marketing ManagerReveal Email/Phone
8
Digital Marketing Operations ManagerReveal Email/Phone
9
Digital Marketing ManagerReveal Email/Phone
10
Manuscript EditorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.7M509%N/AN/A
#2
$8.4M435%N/AN/A
#3
$128.5M4233%N/AN/A
#4
$51.3M1921%N/AN/A
#5
$2.2M150%N/AN/A
#6
$12.5M5727%N/AN/A
#7
$0.5M40%N/AN/A
#8
$26.2M108N/AN/AN/A
#9
$1M8-87%N/AN/A
#10
$16M736%N/AN/A
Add Company

What Is NEJM Group?

NEJM Group brings together the people and products that have made the New England Journal of Medicine, NEJM Journal Watch, NEJM Knowledge+, and NEJM Catalyst, leaders in providing the medical knowledge health care professionals need to deliver the best patient care. The goal of NEJM Group is to meet the rapidly growing demand for essential medical information and to disseminate that content in new ways to a broader global health care community than ever before. Our publications reach health care professionals around the globe — making connections between clinical science and clinical practice that advance medical knowledge, health care delivery, and patient outcomes. NEJM Group is a division of the Massachusetts Medical Society. Follow us on Twitter: @NEJMGroup.

keywords:N/A

N/A

Total Funding

284

Number of Employees

$75.9M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NEJM Group News

2022-04-13 - Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for ...

Five cases of severe or critical Covid-19 and two Covid-19–related deaths occurred, all in the placebo group. Conclusions. A single dose of...

2022-03-30 - Pulse Oximetry for Monitoring Patients with Covid-19 at Home ...

Patients in the pulse oximetry group were provided a pulse ... of this letter at NEJM.org; the trial protocol is also available at NEJM.org.

2022-03-22 - Effect of Early Treatment with Ivermectin among Patients with ...

Overall, 100 patients (14.7%) in the ivermectin group had a primary-outcome event, as compared with 111 (16.3%) in the placebo group...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$85.8M2896%N/A
#2
$46.4M291-6%N/A
#3
$49M29737%N/A
#4
$71M2988%N/A
#5
$60.3M3002%N/A